Search

everythinglearnresearchcommunity

for

Search:↓

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Early sunburn treatment with certain inhibitors may reduce skin cancer risk.

Inactivating both p53 and Rb genes in mice speeds up aggressive skin cancer development.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

TYK2 inhibitors show promise for treating cancer and autoimmune disorders.

Hydroxychloroquine may help treat benign prostatic hyperplasia by reducing inflammation and promoting cell death.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.

A woman's adrenal tumor disappeared after treatment with cyproterone acetate.

Upadacitinib may effectively treat resistant lichen planopilaris.

Intralesional pentoxifylline effectively and safely treats alopecia areata, improving hair regrowth.

Finasteride may affect PNMT, causing side effects.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Platelet-rich fibrin may help reduce nonmelanoma skin cancer cell growth.

MCPIP1 in myeloid cells is important for skin cancer development and healthy hair growth.

Pentoxifylline helps hair regrowth in rats with hair loss.

JAK1 inhibitor may effectively treat alopecia areata when TNF-α inhibitors and corticosteroids fail.

P-3074 effectively blocks scalp DHT better than oral finasteride.

PRP is a promising alternative for alopecia areata due to its safety and patient satisfaction.

Loss of the p53 gene alone causes tumors, and losing both p53 and Rb genes speeds up aggressive skin cancer.

A new peptide, murikal/SPR4, was found to significantly increase hair growth in mice, and its liposomal topical formulations enhanced hair growth more than commercial products. However, results on human scalp skin were unclear, needing more tests.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Compound 15a was effective in inhibiting 5α-reductase.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Trametinib can cause skin issues, but they can often be managed without stopping the drug.

HA-P5 effectively treats acne without causing side effects seen in other treatments.